The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end ...

Vertex Pharmaceuticals (NASDAQ ... These products work by correcting a faulty protein that causes symptoms of the disease. Different genetic mutations cause different problems with this particular ...

H.C. Wainwright has recently reiterated Vertex Pharmaceuticals Inc (VRTX) stock to Buy rating, as announced on Today, according to Finviz. Earlier, on December 19, 2024, Oppenheimer had reduced the ...

Vertex Pharmaceuticals said Friday the U.S. Food ... encompassing more patients with different types of mutations of the disease. The medicine, called trikafta, can treat cystic fibrosis patients ...

NEW YORK, NY / ACCESSWIRE / December 20, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex Pharmaceuticals Incorporated ("Vertex Pharmaceuticals") ...

This approval will allow many of the patients with the disease to access a new therapy option. The approval of ALYFTREK by the FDA is a key development for Vertex Pharmaceuticals, as it ...

CNBC’s Jim Cramer delivers his daily Mad Dash. Luigi Mangione, CEO killing suspect, pleads not guilty to state terror and murder charges in Manhattan court Congress ...

The best diabetes medication for kidney disease can vary depending on the severity of your kidney damage. You may need a medication that doesn’t require dose adjustment based on your kidney ...

Vertex Pharmaceuticals (NASDAQ:VRTX) faces a potential downside in its stock price, as indicated by RBC Capital’s price target. The company’s stock experienced a significant decline following ...

In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against the other stocks Jim Cramer talked about this week. Jim Cramer, host of Mad ...

Vertex Pharmaceuticals shares fell after the company reported mixed results from a study of a treatment for patients with lumbosacral radiculopathy, a neurological disorder that causes back and ...

Hardman Johnston Global Equity highlighted stocks like Vertex Pharmaceuticals Incorporated ... We’re talking disease prediction, hyper-personalized marketing, and automated logistics that ...